Wanbury Limited announced the successful completion of an inspection by the Brazilian Health Regulatory Agency (ANVISA) at its manufacturing facility in Tanuku, Andhra Pradesh. The inspection was conducted from December 16 to December 20, 2024.
According to Wanbury, the inspection concluded with zero observations, indicating full compliance with ANVISA’s regulatory standards. The facility was evaluated for adherence to Current Good Manufacturing Practices (cGMP), which are required for pharmaceutical manufacturing.
Following the inspection, ANVISA granted the Good Manufacturing Practices (GMP) Certificate to the Tanuku facility. The Certificate of Good Manufacturing Practices (Certificado de Boas Práticas de Fabricação – CBPF) has been issued in both English and Portuguese.
This certification is necessary for the export of pharmaceutical products to Brazil and demonstrates the facility’s compliance with Brazilian regulatory requirements.
